Moderna has long been a darling of investors but it wasn't until the coronavirus pandemic came along that the Cambridge, Massachusetts-based biotech company could prove the value of its new vaccine technology and mint some new billionaires.
Moderna announced on Monday that its experimental vaccine against the coronavirus was 94.5 percent effective, about the same efficacy as the common vaccine against measles.
The announcement sent the share price of the company founded just a decade ago soaring on the NASDAQ in New York. Since January, Moderna has seen its share price quintuple.
Frenchman Stephane Bancel, 48, who has served as chief executive officer of Moderna since 2011, became a billionaire in April, when the very preliminary results of clinical trials on a Covid-19 vaccine were first published.
Bancel is currently worth some $3 billion through his nine percent stake in the company, according to Forbes magazine.
Numerous investors have put their money on the biotech startup during the past decade in part due to the salesmanship of the Moderna CEO.
In 2018, Moderna set a record for an initial public offering by a biotech firm, raising more than $600 million.
The promising new technology attracted not only the attention of Wall Street but also that of the scientific community and a Nobel Prize winner is among the eminent advisors to the company.
Two of the founders and early investors in Moderna were Harvard University professor Timothy Springer and Robert Langer of the Massachusetts Institute of Technology (MIT).
They both became billionaires this year, according to Forbes.
Speaking in 2012, another co-founder, Noubar Afeyan, said: "Moderna's promise rivals that of the earliest biotechnology companies over 30 years ago -- adding an entirely new drug category to the pharmaceutical arsenal in the fight against important diseases."
'Warrior'
Despite its promise, the company has not yet brought a product to market and the Covid-19 vaccine still needs the approval of health authorities before it can be shipped.
Moderna uses synthetic versions of molecules called "messenger RNA" to hack into human cells and effectively turn them into vaccine-making factories.
The concept was first developed in the 1990s, but it wasn't until the mid-2000s that a way was found to modify synthetic RNA to prevent it from triggering a dangerous inflammatory response.
One of Moderna's first projects was to try to develop targeted vaccines against various types of cancer, research which is still underway.
But Moderna quickly pivoted to addressing viruses and several clinical trials are taking place involving the Zika virus, Epstein-Barr and others.
His former boss Alain Merieux at French diagnostics company bioMerieux told the newspaper Echos that Bancel has a "warrior temperament."
When it comes to saving lives, Bancel does not deny being a hard taskmaster.
"You want to be the guy who's going to fail them?" Bancel asked in a 2016 interview with the website Stat about working conditions at Moderna. "I don't.
"So was it an intense place?" he said. "It was. And do I feel sorry about it? No."
Moderna, which employs more than 1,000 people, about half at a factory in Massachusetts, does not have the production facilities needed to make the huge amounts of vaccine that will be needed around the world.
With US government assistance, it has formed partnerships with pharmaceutical firms with factories in the United States and Europe: Lonza, Rovi, Catalent.
The ever-optimistic Bancel has promised between 500 million and one billion doses in 2021 and hopes to have approximately 20 million doses ready to ship in the United States by the end of the year, first for high-risk groups and later for children.
"We are very soon going to start a study in teenagers, and I'm hopeful that we might get the result by the summer," he told Fox Business.
"So if a vaccine is proved to be effective and safe in children... they could potentially be vaccinated next summer so that they go back to school in September '21."
AFP RELAXNEWS
Tue Nov 17 2020
Moderna says its experimental vaccine against coronavirus is 94.5 percent effective - GETTY IMAGES/AFP/File
Peniaga nasi kukus raih jualan RM14,000 sebulan
Inisiatif Pendapatan Rakyat (IPR) mampu merubah graf pendapatan bulanan peserta apabila meningkatkan hasil jualan.
Piala Uber: Malaysia tewas kepada Taiwan
Malaysia memulakan kempen Kumpulan B Piala Uber 2024 mereka dengan langkah kiri apabila tewas 1-4 kepada Taiwan, di sini hari ini.
Imigresen tahan dalang warga Indonesia, jual produk kosmetik tanpa kelulusan KKM
Jabatan Imigresen menahan seorang wanita warga Indonesia berusia 50 tahun disyaki menjadi dalang penjualan produk kosmetik dan kecantikan yang tidak mendapat kelulusan KKM.
Sheriff: 9 hari tayangan, kaut RM28 juta!
Filem arahan Syafiq Yusof, Sheriff: Narko Intergriti kini meraih kutipan sebanyak RM28 juta dalam 9 hari tayangan.
Jaheaik sudah panggil artis wanita tular buat persembahan - Exco
Jaheaik sudah panggil artis wanita tular buat persembahan - Exco
KidDin bergabung jawab segala isu Konsert Search 'Gemuruh'
KONSERT Search 'Gemuruh' nampaknya semakin diperkatakan disebabkan beberapa isu yang ditimbulkan sehari dua ini.
Penunjuk perasaan Palestin tempelak wartawan AS
Mereka menuduh wartawan A.S sembunyikan dan berikan gambaran salah mengenai perang di Gaza.
Lawatan ke Riyadh: Blinken melawat Arab Saudi esok
Setiausaha Negara Amerika Syarikat, Antony Blinken akan melawat Arab Saudi pada Isnin untuk bertemu dengan rakan serantau dan membincangkan usaha mencapai gencatan senjata di Gaza dan pembebasan tebusan Israel.
Iraq lulus akta penjara maksimum 15 tahun
Parlimen Iraq meluluskan undang-undang yang menjenayahkan hubungan sejenis dengan hukuman penjara maksimum 15 tahun pada Sabtu.
PRK Kuala Kubu Baharu: MB nafi rumah terbuka Selangor langgar akta
Penganjuran Rumah Terbuka Aidilfitri Peringkat Negeri Selangor yang diadakan pada Sabtu malam di pekan Kuala Kubu Bharu (KKB) di sini, tidak melanggar Akta Kesalahan Pilihan Raya 1954 (AKPR).
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".
Negara berdepan ketirisan subsidi diesel serius - Amir Hamzah
Negara kini sedang berdepan isu ketirisan subsidi diesel yang serius dan wujud kemungkinan terdapat pihak yang tidak layak masih menikmati subsidi itu, kata Menteri Kewangan II Datuk Seri Amir Hamzah.
Kematian akibat kemalangan jalan raya lebih tinggi daripada COVID-19 - Anthony Loke
PDRM akan mengeluarkan data mengenai kemalangan jalan raya pada setiap hari, bukan setahun sekali seperti diamalkan sebelum ini.
Ismail Sabri ziarah lapan beradik yatim piatu akibat COVID-19
Ismail Sabri tiba kira-kira jam 2 petang di kediaman lapan beradik itu di Taman Adenium, Bukit Beruntung pada Selasa.
Teori konspirasi 'Penyakit X'
Ahli teori konspirasi AS sekali lagi membuat 'keuntungan' selepas PBB memberi amaran tentang wabak lebih berbahaya iaitu 'Penyakit X'.
Reformasi dasar, kukuhkan perlindungan, produktiviti pekerja tidak formal
Reformasi dasar perlu dilakukan dalam usaha meningkatkan perlindungan dan produktiviti pekerja tidak formal di Malaysia.